1. Background
2. Objectives
3. Patients and Methods
3.1. Injection Method
4. Results
| Wart Size, mm | Complete Cure | Partial Cure | No Cure | Total |
|---|---|---|---|---|
| ≤ 10 | 31 | 7 | 1 | 39 |
| 11-21 | 51 | 11 | 1 | 63 |
| > 20 (numerous lesions located in a site) | 13 | 13 | 2 | 28 |
| Total | 95 | 31 | 4 | 130 |
The Official Journal of Skin and Stem Cell Research Center
Image Credit:J Skin Stem Cell
Authors
Warts are benign tumors of the skin and mucosa and are caused by human papilloma virus (HPV). They are one of the most common skin diseases found mainly in children and adolescents. Although most of the warts disappear spontaneously or respond to the usual therapeutic measures, resistant forms of the warts impose a problem in dermatology. Intralesional injection of bleomycin has been tried in the treatment of resistant warts with variable results in different studies.
This study aimed to assess the efficacy of intralesional injection of bleomycin in resistant warts.
In this cross-sectional study, a total of 130 warts in 30 patients were treated with 1 mg/mL intralesional injection of bleomycin. Patients received one to three doses of bleomycin every four weeks, and were followed for six months. Response to the treatment was categorized as complete resolution, partial resolution, and nonresponsive. We employed SPSS version 13 to perform t test and analysis of variance (Anova) as statistical methods for analyzing the data.
Out of 130 warts, 126 (97%) cases showed resolution after bleomycin injections. Ninety-five warts (73%) showed complete resolution and 31 (24%) cases showed incomplete resolution. The cure rate (80%) was better in warts with the size smaller than 20 mm in diameter in comparison with larger lesions (46%). After six months follow-up, 7 patients showed recurrence. Recurrence was seen more among those with greater number of warts.
This form of treatment for resistant warts would be reliable, safe, and acceptable to the patients if it is performed under care and with proper dose and concentration.
| Wart Size, mm | Complete Cure | Partial Cure | No Cure | Total |
|---|---|---|---|---|
| ≤ 10 | 31 | 7 | 1 | 39 |
| 11-21 | 51 | 11 | 1 | 63 |
| > 20 (numerous lesions located in a site) | 13 | 13 | 2 | 28 |
| Total | 95 | 31 | 4 | 130 |
Implication for health policy/practice/research/medical education:With regard to the different results reported about this treatment, the present study aimed to evaluate the efficacy of this method on resistant warts including its effect on lesion size in different parts of the body.
Authors’ Contribution:All authors participated equally in this study.
Financial Disclosure:There was no financial disclosure for the research.
Funding/Support:There was no funding support for the research.
Copyright © 2014, Skin and Stem Cell Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Mirashrafi F, Karvanian S, Rahavi-Ezabadi S, Mehdizadeh M, Rabbani Anari M, et al. Bleomycin Efficacy in Treatment of Head and Neck Lymphatic Malformations: Case Series of Patients Presenting to a Tertiary Children's Hospital in Iran from 2017 to 2021. Inn J Pediatr. 2026;36(3):e162488. doi: https://doi.org/10.5812/ijpediatr-162488
Jannati P, Aref S, Jannati AA, Jannati F, Moravvej H. Comparison of Therapeutic Response of Keloids to Cryotherapy Plus Intralesional Triamcinolone Acetonide or Verapamil Hydrochloride. J Skin Stem Cell. 2015;2(1):e29284. doi: https://doi.org/10.17795/jssc2928
Mapar MA, Omidian M, . Intralesional injections of metronidazole versus meglumine antimoniate for the treatment of cutaneous leishmaniasis. Jundishapur J Microbiol. 2010;3(2):. doi:
Asgari A, Taheri A, Babaei A. A Comparison of Two Treatment Methods, Trichloroacetic Acid, and Laser Therapy, in the Wart Treatment: A Randomized Double-Blind Clinical Trial in a University Hospital in Tehran, Iran. Ann Mil Health Sci Res. 2022;20(4):e134671. doi: https://doi.org/10.5812/amh-134671
Nilforoushzadeh MA, Jaffary F, Derakhshan R, Haftbaradaran E. Comparison Between Intralesional Meglumine Antimoniate and Combination of Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis: A Randomized Clinical Trial. J Skin Stem Cell. 2014;1(1):e16633. doi: https://doi.org/10.17795/jssc16633
Last Update: 1 month ago
Last Update: 1 month ago
Last Update: 1 month ago
Last Update: 1 day ago
Last Update: 14 hours ago
Last Update: 6 days ago